Otrexup 10 mg/.4mL
methotrexate · INJECTION, SOLUTION · Antares Pharma, Inc.
No Recall HistoryCurrently in Shortage
Plain English
Otrexup is a injection, solution containing methotrexate at 10 mg/.4mL, taken subcutaneous. Manufactured by Antares Pharma, Inc..
Key Facts
- Brand Name
- Otrexup
- Generic Name
- methotrexate
- NDC Code (Product)
54436-010- Manufacturer
- Antares Pharma, Inc.
- Strength
- 10 mg/.4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA204824
- Drug Class
- Folate Analog Metabolic Inhibitor [EPC]
- Marketing Start
- 10/11/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is Otrexup used for?
Otrexup contains methotrexate. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Otrexup a controlled substance?
Otrexup is not classified as a controlled substance by the DEA.
What is the generic name for Otrexup?
The generic name for Otrexup is methotrexate. There are 10 other brand versions of methotrexate.
What is the NDC code for Otrexup 10 mg/.4mL?
The NDC (National Drug Code) for Otrexup 10 mg/.4mL is 54436-010, listed by Antares Pharma, Inc..